The Pharma Data

JANUARY 26, 2021

Eli Lilly’s bamlanivimab targets different sites on the SARS-CoV-2 spike protein. VIR-3434 is an HBV-neutralizing monoclonal antibody designed to block entry of all 10 genotypes of HBV into hepatocytes and reduce the level of virions and subviral particles in the blood.

Antibody 52

Antibody Genotype Trials Nurses 52

The Pharma Data

MARCH 16, 2022

TIB Molbiol offers a broad range of VirSNiP variant test kits for the detection of key spike protein mutations. The company launched eight RUO VirSNiP test kits for use on LightCycler® and cobas z 480 analyzers, for the detection of key spike protein mutations present in the novel B.1.1.529 1.1.529 Omicron SARS-CoV-2 variant.

In-Vitro 52

In-Vitro Genotype Reagent Protein 52

The Pharma Data

APRIL 7, 2021

Trodelvy is directed to the Trop-2 receptor, a protein frequently expressed in multiple types of epithelial tumors, including TNBC, where high expression is associated with poor survival and relapse. Trodelvy also extended median overall survival (OS) to 11.8 months vs. 6.9 months (HR: 0.51; 95% CI: 0.41-0.62; About Trodelvy.

HR 52

HR Genotype FDA Approval Genotoxicity 52

Roots Analysis

AUGUST 12, 2024

Such test can be used for gene expression profiling, genotyping and detecting chromosomal abnormalities. Protein Based Assays- These tests measure the presence and levels of specific proteins, which can serve as biomarkers for various diseases. Examples includes microarrays and fluorescence in situ hybridization.

Genetics 40

Genetics Gene Expression RNA DNA 40

XTalks

DECEMBER 12, 2023

Efficacy: By comparing with baseline data, clinicians can discern changes in key imaging biomarkers, from the size of brain structures like grey matter, white matter and CSF, to the size of an infarct or the presence of specific proteins like tau or amyloid.

Trials 111

Trials Clinical Trials Clinical Trials Genetics 111

The Pharma Data

MARCH 25, 2021

SG is a first-in-class therapy targeting Trop-2, a protein frequently expressed in multiple types of epithelial tumors, such as TNBC, where high expression is associated with poor survival and relapse. More information about ASCENT is available at [link]. About Sacituzumab Govitecan-Hziy.

Genotoxicity 52

Genotoxicity Genotype Containment Protein 52

The Pharma Data

APRIL 14, 2021

The incidence of Grade 3-4 neutropenia in genotyped patients was 67% in patients homozygous for the UGT1A1*28, 46% in patients heterozygous for the UGT1A1*28 allele and 46% in patients homozygous for the wild-type allele. More information on TROPiCS-04 is available at [link]. About Trodelvy.

Genotype 52

Genotype Containment FDA Approval Genotoxicity 52

Roots Analysis

AUGUST 31, 2023

The nutrigenomic testing employs various techniques / tools to determine the effect of diet on genome; these tools have been described below: Tools for Nutrigenomics Testing Microarray Technologies: These types of technologies have enabled the study of physiological effect of different nutrition, such as proteins and other dietary components.

Genome 40

Genome Genomics Genetics Gene 40

The Pharma Data

NOVEMBER 24, 2020

Management options to date were limited to hyperhydration, crystallization inhibitors and, in a minority of patients with a specific genotype, pyridoxine (vitamin B6). This is a revolutionary approach with the potential to transform the care of patients with genetic and other diseases.

FDA Approval 52

FDA Approval Production RNA Medicine 52